Genome-wide association studies (GWAS) have shown a striking coincidence of MS-risk alleles in the IL-6-, IL-12-, and IL-23-induced STAT-pathways in patients with RRMS [2,3,4]. The gene discussed is IL6; the disease is relapsing-remitting multiple sclerosis.